BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration ...

Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients ...

Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

Americans Skip Overseas Travel as Stem Cell Therapy Arrives at 5 U.S. Locations Aventura, United States - July 5, 2026 ...

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a ...

Casgevy also now indicated for transfusion-dependent beta thalassemia in children 2 years ...

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.